Chronic News and Research

RSS

Amgen reports $3,816 million for 2010 third quarter revenue

Amgen reported revenue unchanged for the third quarter of 2010 at $3,816 million versus $3,812 million for the third quarter of 2009.

26 Oct 2010

Northern Territory reports worst mosquito plague ever

Authorities in Australia’s Northern Territory report the worst mosquito plague since records began in 1979. An organization helping homeless people in Darwin is distributing insect repellent and coils to combat the mosquito onslaught.

25 Oct 2010

Immune Network enters letter of intent to acquire Immunitor oral vaccine technology

Immune Network Ltd. advises that a clinical trial of V5 Immunitor oral vaccine was published earlier this month demonstrating an unexpected powerful effect against tuberculosis, including multi-drug-resistant tuberculosis (MDR-TB) and tuberculosis that is complicated by co-infection with HIV and hepatitis C (HCV).

25 Oct 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden.

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Neptune launches Onemia medical food

Neptune Technologies & Bioressources Inc. enters the pharmaceutical market with the launch of Onemia™, the first medical food of Neptune's subsidiary Acasti Pharma Inc.. Only two years since its foundation, Acasti has completed the development and launch of "Onemia™" on October 21, 2010 at the Cardiometabolic Health Congress meeting in Boston.

25 Oct 2010

CARTaGENE database meets 20k participant milestone

This week, the last questionnaire was filled out and the final vial of blood was drawn, closing CARTaGENE's first ambitious goal of collecting samples and data from 20 000 Quebecers.

25 Oct 2010

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

HRSA has awarded $1.6 million to support the Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The program is designed to establish practice models for the prevention and treatment of sickle cell disease through the coordinated efforts of providers, key stake holders, affected individuals and their families.

25 Oct 2010

Saint Francis HealthCare Partners and Phytel partner to achieve NCQA recognition

Saint Francis HealthCare Partners announced today that it has selected Phytel to help achieve NCQA recognition as a patient-centered medical home and will be rolling out Phytel's unique care coordination and population health management solution, Proactive Patient Outreach, in November.

25 Oct 2010

BAFF protein can promote aggressive leukemia and lymphomas

Chronic lymphocytic leukemia (CLL) cells survive and thrive not just by their own innate wiles, but by also acquiring aid and support from host cells in their surrounding environment.

25 Oct 2010

Taste receptors in lungs can revolutionize treatment option for asthma

Taste receptors in the lungs. Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the receptors could revolutionize the treatment of asthma and other obstructive lung diseases.

25 Oct 2010

Intestinal microbiota can increase broccoli’s cancer-preventive power: Research

A University of Illinois study has shown for the first time that sulforaphane, the powerful cancer-fighting agent in broccoli, can be released from its parent compound by bacteria in the lower gut and absorbed into the body.

22 Oct 2010

New assessment tool to measure cognitive representation of chronic disease

What do we mean by "common sense" when we talk about a disease? What affects the ideas and beliefs that patients have of their disease. Researchers at the University of Granada have developed a test for measuring and assessing chronic patients' cognitive representation of their disease. This advance will enable the development of clinical psychological treatments much more efficient than those currently employed.

22 Oct 2010

Scorpion’s toxins can reduce heart bypass failures: Research

A toxin found in the venom of the Central American bark scorpion (Centruroides margaritatus) could hold the key to reducing heart bypass failures, according to research from the University of Leeds.

22 Oct 2010

Diamyd Medical to divide operations into two business areas

In her comments in today's year end report, Elisabeth Lindner, President and CEO of Diamyd Medical, states that the company has decided to divide its operations into two business areas beginning with the new 2010/2011 fiscal year; Diabetes and Pain.

22 Oct 2010

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the 24th Annual North American Cystic Fibrosis Conference (NACFC) October 21-23, 2010 in Baltimore, Maryland.

22 Oct 2010

New epilepsy drugs give more options, but make treatment decisions more complex: Epilepsy specialist

A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a Loyola epilepsy specialist reports in the journal Neurologic Clinics.

22 Oct 2010

Researcher receives grant to conduct study on brain development of children who stutter

A Michigan State University researcher is hopeful that a recent National Institutes of Health grant she received will result in better treatment options and, ultimately, better lives for children who stutter.

22 Oct 2010

Patients are under-informed about treatments; Home-based care gains popularity

A survey of more than 3,000 patients age 40 and older reveals that physicians often leave information out when they present treatment plans to patients, who "hear far more from doctors about the pros than cons of medications, tests and surgeries." Often, "physicians tend to offer opinions, not options, the researchers found, and rarely mention to patients that they can decide not to do anything," according to the study, which was funded by the Foundation for Informed Medical Decision Making.

22 Oct 2010

Cephalon signs convertible note subscription agreement with ChemGenex Pharmaceuticals

Today, Cephalon, Inc. announced the signing of a convertible note subscription agreement with ChemGenex Pharmaceuticals Limited, an Australian-based oncology focused biopharmaceutical company.

22 Oct 2010

Chronic News and Research

Amgen reports $3,816 million for 2010 third quarter revenue

Northern Territory reports worst mosquito plague ever

Immune Network enters letter of intent to acquire Immunitor oral vaccine technology

Non communicable diseases will cost India USD237 billion during 2006-15

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Neptune launches Onemia medical food

CARTaGENE database meets 20k participant milestone

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

Saint Francis HealthCare Partners and Phytel partner to achieve NCQA recognition

BAFF protein can promote aggressive leukemia and lymphomas

Taste receptors in lungs can revolutionize treatment option for asthma

Intestinal microbiota can increase broccoli’s cancer-preventive power: Research

New assessment tool to measure cognitive representation of chronic disease

Scorpion’s toxins can reduce heart bypass failures: Research

Diamyd Medical to divide operations into two business areas

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

New epilepsy drugs give more options, but make treatment decisions more complex: Epilepsy specialist

Researcher receives grant to conduct study on brain development of children who stutter

Patients are under-informed about treatments; Home-based care gains popularity

Cephalon signs convertible note subscription agreement with ChemGenex Pharmaceuticals

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News